INTRODUCTION
The sporozoan parasite, Toxoplasma gondii, is an intracellular coccidian tissue protozoa which is a common cause of toxoplasmosis in humans and animals, particularly immunocompromised hosts [1] . It is reported that approximately one third of the world's current population has been infected with this parasite [2] . The World Health Organization considers toxoplasmosis one of the major parasitic diseases infecting humans in the developing countries [3] . This status is reflected by the parasite's worldwide distribution and broad range of intermediate hosts [4] that have resulted in the infection of up to 1 billion people [5] . Most toxoplasmosis cases are reported in South America, Middle East and other lowincome countries with high seropositivity against T. gondii infection in either normal or immunecompromised hosts [6] .
Toxoplasmosis is treated with a combination of sulfadiazine and pyrimethamine which are both key enzyme inhibitors in the biosynthesis of pyrimidines [6] . However, these drugs cause adverse reactions, including the suppression of bone marrow, teratogenic effects in the first trimester of pregnancy, and sulfadiazine hypersensitivity [7] . Other drugs such as clindamycin, atovaquone, daspone, trimethoprim, pentamidine, and azithromycin have also been used, but side-effects such as diarrhoea, nausea, abdominal pain, cholestatic hepatitis, hepatomegaly, and hepatitis have been reported [8] . Cultural knowledge pertaining to the application of medicinal plants in the treatment of parasitic infection represents a vital role in the discovery of safe and natural chemotherapeutic agents against toxoplasmosis [9] .
Traditionally, the leaves of P. sarmentosum are used to treat malaria, coughs and colds, backache and joint pain, toothache, and worm infections [10] . Thus, the present study aims to investigate the anti-Toxoplasma activity of the ethanolic extract of P. sarmentosum leaves on T. gondii in the inoculated Vero cells.
EXPERIMENTAL Plant materials
The leaves of Piper sarmentosum were collected from the vicinity of Universiti Putra Malaysia. Authentication of the species was based on published taxonomical nomenclatures [11] . The leaves of Piper sarmentosum were rinsed thoroughly with multiple changes of distilled water and oven-dried at 50 °C before being ground into powder. Extraction was carried out by macerating 100 g of powdered leaves with 500 mL of 95 % ethanol at room temperature for 24 h. The extract was then filtered through Whatman no. 1 filter paper. After filtration, the extract was evaporated under reduced pressure using rotary evaporation. The RPMI-1640 medium (Gibco BRL) was used as the solvent for the preparation of various dilutions of the ethanolic extract. Concentrated stock solution of each ethanolic extract was prepared by adding a known weight of each ethanolic extract to a known volume of RPMI-1640 medium, and then serially diluted (1:2) to obtain the working solutions at different final concentrations.
Vero cell line
Vero cells were maintained in a growth medium consisting of RPMI-1640 supplemented with 10 % FBS (Gibco BRL), (Gibco BRL), 100 units/mL penicillin (Gibco BRL) and 100 μg/mL streptomycin (Gibco BRL). Clindamycin (SigmaAldrich Corp) was used as the reference control drug. The cells were cultured and maintained at 37 °C in a humidified 5 % CO 2 incubator.
Toxoplasma gondii RH strain
The tachyzoites from the virulent RH strain of T. gondii were harvested from the peritoneal fluid layer of infected Balb/c mice in phosphatebuffered saline (PBS), pH 7.2. The peritoneal fluid obtained was then centrifuged at 1500 rpm for 10 min at room temperature to remove host cells and debris as mice host cells were found in the peritoneal fluid layer. The pellet was washed twice with RPMI-1640 supplemented with glutamine (2 raM), penicillin (100 units/mL), and streptomycin (100 μg/mL). The tachyzoites T. gondii were inoculated to the Vero cell and grown in a 25mL tissue culture flask at 37°C in a humidified 5 % CO 2 incubator.
MTT assay
Cytotoxicity of the ethanol extract of P. sarmentosum on Vero cells was determined using 3-(4, 5-dimethylthiazol-2-yl) -2,5-diphenyltetrazolium bromide MTT assay which was published by Mosmann [12] ; however, some modifications were made to this method. Vero cells were seeded at a density of 6 x10 4 cells/mL in each well of a 96-well plate containing 100μL of the growth medium. The plate was incubated at 37 ºC in a humidified 5 % CO 2 incubator for 24 hrs. The cells were treated with the ethanol extract of P. sarmentosum, which was serially diluted using the growth medium to obtain the various final concentrations of 200, 100, 50, 25, 12.5, 6.25 and 3.125 μg/mL. 100 μL of each concentration was added into each respective 96-well plate. In this study, clindamycin, a known drug for treating toxoplasmosis was used as the reference (positive) control drug, and RPMI was used as the control buffer. After 24 h of treatment, 200μL of the medium was aspirated out and 100 μL of MTT -PBS (5 mg/mL) solution in RPMI medium in the ratio of 1: 9 was added to each well. The plate was then covered with aluminium foil and incubated for 4hrs in a 37 ºC incubator. The medium was then discarded and 100μL of DMSO was added into each well to solubilise the dark-blue MTT formazan salt. The optical density was measured at 570 nm absorbance using a Dynex Microplate Reader; higher concentrations can cause toxicity in Vero cells. Growth inhibition (GI) was calculated as in Eq 1.
GI (%) = {(At -Ac)/Ac}100 …………….. (1) where At and Ac are the absorbance of treated cells and control, respectively.
Determination of anti-Toxoplasma activity and cytotoxicity
The inoculated Vero cells were harvested from the culture flask during the exponential growth of the cells at day 2, post-inoculation, with the cell density of 6 × 10 4 cells/mL cultured in 96-well plates. Following this, 3 × 10 5 mL of Toxoplasma gondii was added to each well with the parasite to cell ratio of 5:1 for Vero cell inoculation; this ratio was based on a previous study by Belloni [13] . Six hours after inoculation, the inoculated cells were washed twice with RPMI to remove any non-adherent parasites. After 18 hours of incubation, 200μL RPMI supplemented with 2 % FBS was added to each well following the methods developed by Sheng [14] . After 24 hours of treatment, the anti-T. gondii activity and cytotoxicity of the ethanol extracts of P. sarmentosum were evaluated using the MTT method. The optical density reading on the microplate reader at 570nm was represented by the mean of three independent experiments. The median inhibitory concentration (IC 50 ) value was calculated based on the concentration of ethanol extracts of P. sarmentosum and clindamycin that successfully inhibited 50 % of T. gondii. AntiToxoplasma activity was expressed as selectivity index (SI) based on the mean of the IC 50 values for Vero cells, relative to the mean of the IC 50 value of T. gondii as shown in in Eq 2 [15] . SI (%) = (V-IC 50 /T-IC 50 )100 ………. (2) where V-IC 50 and T-IC 50 are the median inhibitory concentrations required to inhibit Vero cell and T. gondii, respectively.
Microscopic examination of tachyzoites
Vero cells were cultured on a glass cover slip inside a 35mm petri dish until confluent, before being inoculated with 1×10 4 tachyzoites of T. gondii. After incubation for 4 hours, the monolayers formed on the glass cover slip were washed with a Hanks balanced salt solution (HBSS) (Gibco BRL). The ethanol extract of P. sarmentosum and clindamycin was then added to each glass cover slip and incubated for 24 h at 37 ºC. After incubation, the glass cover slips were washed twice with HBSS and fixed with methanol prior to staining with Giemsa (SigmaAldrich Corp). All the prepared samples were observed using Nikon (model-Nikon Eclipse 50i) microscope and the images were captured using (NIS-Elements D, Japan). Qualitative analysis methods were used as an alternative to quantitative analysis.
Statistical analysis
The statistical analysis was performed using Student's t-test, and differences were considered significant at p < 0.05. The results were analysed using the Statistical Package for Social Sciences (SPSS) version 22 for Windows and are presented as mean ± standard deviation (SD).
RESULTS

Anti-Toxoplasma activity
The results of in vitro anti-Toxoplasma activity against the T. gondii RH strain and selectivity index are summarized in Table 1 and Figure 1 . Anti-Toxoplasma activity was found in all the samples tested as well as high mortality. The highest anti-Toxoplasma activity was found in Clindamycin with IC 50 = 84.0 ± 1.15 μg/mL and Selectivity index = 11.67.
Anti-Toxoplasma activity of the ethanol extracts of P. sarmentosum was comparable to clindamycin with IC 50 = 125.0 ± 1.53 μg/mL and selectivity index = 10.08.
Morphology of anti-Toxoplasma in inoculated Vero cells
Figures 2 and 3 illustrate the morphological effects of RPMI, clindamycin and P. sarmentosum extract on Vero cell and T. gondii inoculated Vero cells. After 24 hours, postinoculation, higher parasitemia were observed in the inoculated Vero cells (Figure 3) . Tachyzoites of T. gondii could be observed inside the Vero cells; the tachyzoites were also adhered to the glass coverslip in the group treated with RPMI. However, when 50 μg/mL clindamycin and P. sarmentosum extract was added, the parasitemia drops and quantities of tachyzoites of T. gondii decreased sharply. Following the first 24 hours, the tachyzoites of T. gondii were infrequently observed in the inoculated Vero cells. No counting was involved in this process, the method was exclusively based on observation. There was no significant change in morphology of Vero cells after exposure to P. sarmentosum extract (Figure 2 and Figure 3 ).
DISCUSSION
Parasitic diseases continue to have huge impact on human health, particularly in tropical regions [16] . New anti-parasitic drugs are urgently required in the treatment and control of parasitic infections such as toxoplasmosis [17] . The identification of an appropriate host to support the growth of the parasite presents a major challenge in anti-parasitic drug discovery. Scientific evidence documenting the antiparasitic properties of medicinal plant extract, derives mainly from in vitro studies. The main advantage of in vitro studies in this context is the ability to detect directly anti-parasitic activity of these extracts or compounds. It is necessary to ensure that the plant extracts are not toxic to the host and will not affect host performance [18] . Plant extracts can be involved in anti-parasitic activity assessment only if the parasitized host benefits from prolonged exposure to the extract. This net benefit can only be achieved if the antiparasitic properties of these extracts do not cause the adverse side effect on the host cell's morphology and performance [19] .
Studies by Villena [20] , demonstrated the efficacy of sulfadiazine and pyrimethamine combination in the treatment of toxoplasmosis. This combination leads to remarkable synergistic activity against the replicating form of T. gondii cysts in tissue through the sequential inhibition of parasite dihydropteroate synthase (DHPS) and dihydrofolate reductase (DHFR). These two major enzymes are responsible for the synthesis of the folate compounds that are essential for the survival and replication of parasites. However, several failures have been reported in the treatment of toxoplasmic encephalitis, chorioretinitis and congenital toxoplasmosis. These failures, relating to the host, may be due to several factors such as drug intolerance, malabsorption, poor compliance to the development of drug-resistant parasites, or lower levels of susceptibility to the parasite strain [20] . The ethanolic extract of P. sarmentosum was tested for potential cytotoxic activity in vitro against Vero cells. It was concluded that the extract was not toxic to Vero cells with IC 50 values of more than 100 μg/ml (Figure 1 ).
It is imperative to first establish whether the plant extracts affect Vero cell performance using the cytotoxicity study. Following the findings (Table 1) , the ethanol extracts of P. sarmentosum were further tested for antiToxoplasma and the potential (Figure 2 ). Anti-toxoplasma activity was found in the sample tested and high mortality of tachyzoites was observed. The extract also exhibited potential T. gondii inhibitory activity with the IC 50 = 12.4 ± 2.08 μg/mL on the parasite growth (Figure 4) . The results of the ethanol extracts of P. sarmentosum leaves were comparable to those of clindamycin (IC 50 = 7.2 ± 1.52 μg/mL) ( Figure 3 and Figure 4 ). A previous study by Saadatnia [21] concluded that the propagation of T. gondii parasites in Vero cells produced high yield and viability of tachyzoites, with minimal host cell contamination. Hence, Vero cells were used as the host cells for T. gondii in the present study to determine the anti-parasitic activity of the plant extracts.
Following the addition of plant extracts to monolayers of Vero cells, the cells remained metabolically active and viable after being infected with Toxoplasma gondii. This study confirmed that Toxoplasma gondii could invade Vero cells and proliferate quickly; it also demonstrated that plant extracts effectively inhibited the growth of Toxoplasma gondii, and were less toxic to Vero cells than clindamycin. This finding signifies that P. sarmentosum could potentially be an alternative to clindamycin for the treatment of toxoplasmosis; this warrants further study.
Normally the rapidly proliferating Toxoplasma gondii tachyzoites propagate by host cell lysis, regression, reattachment, and invasion of new host cells [22] . The significant changes observed in the morphology and confluence of Vero cells in an exclusively RPMI medium treated group (negative control) is likely due to the above fact. However, plant extract did not significantly affect the normal growth and morphology of the infected host cells, despite the potent anti T. gondii activities. The cells seemed to remain metabolically active and viable. In fact, cell proliferation and confluence was greater when compared to exposure to clindamycin. This observation verified that plant extracts had greater anti T. gondii activity and also had no selective toxicity against the infected host cells. Finally, this study confirms P. sarmentosum has potential as an alternative to clindamycin for the treatment of toxoplasmosis.
CONCLUSION
The ethanol leaf extract of P. sarmentosum shows potential anti-parasitic activity against T. gondii. Further study in the identification of the active compounds from this plant in Toxoplasma gondii infected animal models need to be carried out. 
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